Immunic, inc. to participate in upcoming investor and industry conferences

New york , april 25, 2022 /prnewswire/ -- immunic , inc. (nasdaq: imux), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases, today announced participation in the following, upcoming investor and industry conferences: april 27-28: b. riley securities' 2022 virtual neuro & ophthalmology conference.
IMUX Ratings Summary
IMUX Quant Ranking